FOUNDER'S STORY
From the Lab to the Clinic
Dr. Neena Haider founded Shifa Precision to turn complex biology into clear, actionable care.
She saw that DNA, biomarkers, medications, lifestyle, and environment all shape health, but the data lived in disconnected systems. Even subtle molecular differences can change disease risk and treatment response—yet providers had no way to see the whole picture.
OASIS AI unifies these layers into a dynamic Molecular Twin™: a searchable model of each patient that reveals risk earlier and guides smarter decisions. The result is a shift from reactive treatment to proactive, personalized medicine.
Vision & Mission
Empowering every person to live a longer, healthier life.
Redefining health. Predicting earlier. Preventing sooner.
Shifa Precision transforms healthcare from reactive treatment to predictive, preventive, and proactive care, making precision medicine actionable today.
Our Mission
Shifa Precision unifies complex biological data with advanced AI into a digital simulator of each patient – the Molecular Twin™ – to deliver actionable clinical intelligence, empowering earlier detection, smarter intervention, and precision care.
Connected Knowledge
Disease does not occur in isolation, yet healthcare has traditionally viewed patients through disconnected data, systems, specialties, and moments in time. The challenge has never been a lack of information — it has been connecting it all and knowing what it means for the patient in front of you.
Dynamic Molecular Twin
Shifa’s OASIS AI clinical intelligence engine continuously brings together the evolving body of health science with the full spectrum of patient data — from molecular interactions, genomics, and microbiome to clinical history, medications, labs, lifestyle, environment, and devices.
Actionable Intelligence
From this unified view, every meaningful signal becomes actionable clinical intelligence: revealing risk earlier, identifying what is driving disease, evaluating potential interventions, and helping clinicians determine what to do next.
Disease-agnostic and built around the individual, Shifa bridges the knowledge gaps that have made true precision care unattainable by connecting the whole patient to the living body of health science and turning knowledge into action.
The result is a new paradigm of care: predict earlier, prevent sooner, intervene smarter, and give every person the opportunity to live a longer, healthier life.
THE TEAM
The Team Behind the Vision
Our team brings together visionary scientists, clinicians, and innovators dedicated to transforming healthcare. With expertise across genetics, AI, and precision medicine, we empower personalized, proactive care for all.
Leadership
Strategic Business Advisors
Kent Barkouras
Strategic Capital
LinkedIn
Marc Kirshbaum
Strategy and Operations
LinkedIn
Mike Gottlieb, BS
Finance and Accounting
LinkedIn
Trish Mangold, BS
Provider Relations, Brand Ambassador
LinkedIn
Von Cameron, MBA, Retired Captain USAF
Go To Market
LinkedIn
Laura Carabello, BS
Marketing and Communications
LinkedInMEDICAL, TECHNOLOGY AND SCIENTIFIC ADVISORY BOARD
Kristina Holton, Ph.D.
Bioinformatics and AI
LinkedIn
Val Sheffield, MD, Ph.D.
Pediatric Genetics
LinkedIn
Anthony Wynshaw-Boris, MD, Ph.D.
Medical Genetics
LinkedInChris Walsh, MD, Ph.D.
Pediatric Neurology
LinkedIn
Margaret DeAngelis, Ph.D.
Human Genetics
LinkedIn
Arne Nystuen, Ph.D.
Biotechnology Application
LinkedInOUR COLLABORATORS
Who we work with
“We have set a bold goal to make early-stage detection an essential part of the standard of care for all cancers. By doing so, we aim to reduce cancer deaths by 25% in five years and 50% in 10 years.”
Stand Up To Cancer believes partnering with Shifa Precision is a meaningful step toward that goal. By combining AI with the first molecular language model, Shifa Precision helps providers move beyond today’s crisis care—predicting risk, personalizing prevention, and treating patients earlier.
“AMDF believes in supporting bold science with the potential to transform patient care. We supported Dr. Neena Haider’s foundational research toward a revolutionary treatment for macular degenerative diseases, and we are proud that it has since advanced into clinical development, including Phase 3 trials.”
Today, we are excited to see that same, comprehensive scientific vision extended, through Shifa Precision, to the potential to transform medicine and improve health on a global scale.